Biotech Co. Affymetrix Pays $96M To End Investor Suit
Affymetrix Inc. agreed Saturday to repurchase $95.5 million in bonds from investment firm Tang Capital Partners LP and others to settle a putative class action accusing the biotechnology company of stiffing...To view the full article, register now.
Already a subscriber? Click here to view full article